felv
infecti
agent
classif
morpholog
protein
replic
felv
felin
oncornavirusassoci
cell
membran
antigen
focma
biolog
properti
felv
protein
transmiss
felv
pathogenesi
felv
replic
b
felv
genet
agent
structur
viral
rna
structur
locat
signific
felv
proviru
endogen
felin
retrovirus
c
felv
diseasecaus
agent
role
serotyp
viral
recombin
requir
viremia
iii
biolog
respons
cat
felv
hemolymphoreticular
cell
target
felv
replic
vivo
vitro
hemolymphoreticular
cell
effector
felv
restrict
g
c
much
notorieti
attach
felin
leukemia
viru
felv
stem
abil
induc
lymphoma
leukemia
natur
outbr
cat
share
environ
man
leukemia
lyrnphoma
howev
repres
uncommon
manifest
felv
infect
frequent
interact
cat
hemopoietjc
lymphoid
tissu
felv
behav
tripartit
agent
act
ectiou
agent
genet
agent
rare
diseasecaus
agent
moreov
felin
host
exhibit
tridimension
microenvironment
respons
felv
lymphoreticular
marrow
ell
serv
primari
target
viral
replic
primari
effector
viral
restrict
primari
target
felvjnduc
cytoprolif
cytosuppress
diseas
lastli
trinal
rnacroenvironment
influenc
immunobiolog
felv
infect
felvrel
diseas
includ
evolut
felin
social
habit
intercurr
pathogen
felv
infecti
agent
felv
envelop
oncogen
rna
viru
contain
revers
transcriptas
rt
classifi
oncoviru
famili
retrovirida
fenner
certain
viral
protein
defin
contribut
biolog
felv
intern
core
felv
consist
tightli
coil
viral
rna
packag
protect
nucleas
hexagon
arrang
core
protein
dalton
design
c
respect
grave
velic
schafer
bolognesi
core
complex
also
encompass
virion
revers
transcriptas
rt
scolnik
et
al
requir
synthesi
dna
complementari
rna
infecti
felv
core
complex
surround
acid
protein
dalton
constitut
inner
coat
centrifugad
inner
coat
viral
envelop
whose
major
compon
glycosyl
protein
dalton
arrang
sphere
display
radiat
spike
deriv
minor
envelop
protein
mass
dalton
pi
e
follow
adsorpt
penetr
felv
uncoat
rna
copi
singl
strand
complementari
dna
cdna
use
virion
rt
prime
small
trna
molecul
review
varrnu
litvak
araya
de
novo
synthes
dna
serv
templat
format
doublestrand
dna
proviru
circular
integr
becom
part
genom
synthesi
integr
proviru
occur
ceil
undergo
dna
synthesi
temin
viral
rna
vrna
transcrib
integr
proviru
dnadepend
rna
polymeras
translat
host
ribosom
gener
precursor
structur
envelop
polyprotein
polyprotein
migrat
plasma
membran
thicken
lipid
bilay
initi
evagin
known
viral
bud
schafer
bolognesi
bolognesi
et
al
peripher
envelop
precursor
undergo
posttransl
cleavag
minor
fragment
pl
e
span
plasma
membran
transmembran
spike
firmli
embed
lipid
bilay
bolognesi
et
al
protrud
knob
repres
major
fragment
glycosyl
weld
spike
pl
e
disulfid
linkag
bolognesi
et
al
central
structur
precursor
process
individu
protein
reassoci
accord
biochem
biophys
properti
encapsid
ribonucleoprotein
core
grave
velic
chafer
bolognesi
okasinki
velic
pinter
fleissner
felin
oncornavirusassoci
cell
membran
antigen
focma
express
viral
structur
envelop
protein
cytoplasm
ell
product
partial
product
felv
infect
correl
highli
express
cellular
membran
yoshiki
et
al
express
felv
protein
felvinduc
tumor
antigen
howev
discord
felvinduc
hemolymphat
malign
distinguish
common
tumorspecif
antigen
felin
oncornavirusassoci
cell
membran
antigen
focma
present
transform
cell
cat
highli
express
product
felv
infect
cat
minim
express
nonproduct
felv
infect
essex
et
al
b
hardi
et
al
focma
like
present
preneoplast
lyrnphocyt
bone
marrow
mesenter
lymph
node
tice
olsen
recent
investig
use
monoclon
antibodi
suggest
express
focma
partial
express
felv
c
envelop
gene
env
gene
see
section
interdepend
event
vedbrat
et
al
exact
origin
function
focma
remain
specul
clear
antibodi
focma
determin
effect
antitumor
immunosurveil
cat
lymphomafelv
model
essex
et
al
see
section
lbt
major
core
protein
known
major
group
specif
antigen
gsa
confer
interspeci
antigen
cross
reactiv
felv
hardi
et
al
presenc
cytoplasm
circul
neutrophil
platelet
fix
cell
immunofluoresc
assay
hardi
et
al
correl
recoveri
infecti
viru
fisching
et
al
plasma
hoover
et
al
defin
felv
virem
persist
product
see
section
ilialb
state
solubl
serum
gener
measur
enzymelink
immunosorb
assay
saxing
et
al
may
manifest
either
viremia
el
saposit
cat
occult
felv
infect
ellsaposit
cat
lutz
et
al
saxing
et
al
see
section
three
antigenica
ly
distinct
form
major
envelop
glycoprotein
specifi
three
subgroup
serotyp
felv
design
felva
felvb
felv
c
envelop
gene
product
determin
infect
interfer
host
rang
properti
pathogen
subgroupspecif
antigen
evok
viru
neutral
antibodi
respons
import
revers
viremia
cat
regress
felv
infect
sarma
log
schaller
olsen
hardi
et
al
jarrett
russel
russel
viru
adsorpt
henc
infect
depend
upon
affin
host
cellular
felv
receptor
viru
neutral
antibodi
block
initi
adsorpt
dessic
heat
rain
ultraviolet
light
detach
gp
inactiv
felv
minor
envelop
protein
e
caus
profound
depress
lymphocyt
function
accompani
viremia
math
et
al
see
section
lllcl
bind
pi
e
first
compon
complement
bartholomew
esser
activ
classic
pathway
caus
complement
consumpt
result
ineffect
virolysi
cat
kobilinski
et
al
see
section
domest
cat
expos
felv
follow
prolong
contact
saliva
urin
natur
virern
cat
franci
et
al
hoover
et
al
high
titer
infecti
felv
excret
pharyng
salivari
bladder
intestin
epithelia
viru
surviv
room
temperatur
condit
dessic
less
hour
franci
et
al
therefor
e
ficient
viru
transmiss
appear
requir
either
direct
contact
cat
transfer
saliva
hand
teed
utensil
exposur
recent
void
urin
commun
litter
pan
presum
portal
entri
follow
contact
natur
hardi
et
al
arrett
et
al
oronas
pharynx
experiment
oronas
challeng
hoover
et
al
cat
felv
lead
viremia
diseas
nonproduct
infect
immun
see
congenit
transmiss
felv
propos
account
clinic
observ
virem
queen
may
bear
virem
kitten
question
intrauterin
versu
lactationassoci
versu
contact
exposur
kitten
resolv
cotter
et
al
recent
experi
document
transplacent
passag
felv
isol
embryon
hemolymphat
tissu
fetal
kitten
obtain
hysterectomi
virem
gravid
queen
hoover
et
al
six
sequenti
stage
pathogenesi
felv
replic
identifi
use
immunofluoresc
assay
paraffinembed
tissu
section
tabl
see
rojko
et
al
felvhost
cell
contact
initi
lymphoepithelia
follicular
lymphocyt
pharyng
palatin
tonsil
stage
first
day
exposur
dae
via
oronas
instil
viru
next
amplifi
drain
lymph
node
infecti
felv
transport
lymphocyt
macrophag
stage
secondari
site
marrow
system
gutassoci
lymphoid
tissu
galt
massiv
viral
amplif
occur
stage
z
mononuclear
cellassoci
viremia
reminisc
describ
oncogen
epsteinbarr
viru
epstein
achong
nononcogen
virus
felin
panleukopenia
carlson
et
al
provid
rapid
effici
distribut
felv
mitot
activ
cell
marrow
galt
vital
cell
initi
infect
retrovirus
must
enter
mitosi
permit
integr
proviru
support
replic
progeni
infecti
viru
temin
cell
associ
also
protect
felv
reticuloendotheli
clearanc
inactiv
humor
lipid
protein
moieti
describ
felin
welsh
et
al
sherwin
et
al
bartholomew
esser
murin
bovin
retrovirus
welsh
et
al
sherwin
et
al
bartholomew
esser
de
noronha
et
al
schwartz
et
al
gupta
ferrer
prolifer
felv
spleen
lymph
node
galt
distant
site
inocul
evid
cat
dae
stage
felv
concentr
rapidli
divid
lymphoid
cell
germin
center
cortic
follicl
earli
viral
tropism
blymphocyt
see
section
iiiai
mimic
procliv
certain
mulv
strain
germin
center
immunoblast
earli
infect
hanna
et
al
ruddl
et
al
isaak
et
al
fourth
stage
uninfect
clone
granulocyt
monocyt
usual
identifi
rare
eosinophil
precursor
erythroid
seri
cell
intens
felv
replic
invers
relat
cell
matur
replic
earli
erythroid
precursor
extinguish
hemoglobin
nuclear
pyknosi
distinguish
basophil
normoblast
rubricyt
concomit
marrow
infect
onset
multipl
foci
product
infect
crypt
germin
epithelium
small
larg
intestin
viral
antigen
confin
basilar
mitot
cell
popul
absent
matur
distal
absorpt
epithelium
line
villi
retrovirus
gener
cytopath
replic
felv
rapidli
divid
cell
marrow
yrrlphoid
tissu
intestin
associ
overt
cytopath
chang
necrosi
polykaryo
ytosi
et
presenc
felv
lyrnphoid
rnarrow
tissu
howev
may
depress
normal
ceil
turnov
initi
atrophi
see
section
iic
appear
neutrophjl
platelet
circul
consid
fifth
stage
evolut
progress
felv
infect
dae
phase
directli
reflect
infect
marrow
progenitor
onset
el
marroworigin
viremia
hardi
et
al
harbing
persist
virernia
induct
fatal
felvrel
diseas
hardi
et
al
hoover
eta
rojko
et
al
initi
marrow
reieas
fekvinfect
neutrophil
platelet
coincid
exactli
develop
protract
neutropenia
lyrnphopenia
dae
cockerel
et
al
rojko
et
thrombocytopenia
pedersen
et
al
hard
et
al
rojko
et
al
latter
group
el
cat
particular
risk
reactivat
felv
infect
see
section
antigenemia
lutz
et
al
saxing
et
al
rice
olsen
rojko
et
al
cat
fail
develop
vn
focma
ar
tibodi
felv
infect
extend
multipl
mucos
glandular
epitheli
tissu
dae
thereaft
earliest
consist
infect
epitheli
tissu
oropharynx
nasopharynx
larynx
trachea
stomach
salivari
gland
pancrea
urinari
bladder
replic
begin
multipl
foci
mitot
layer
progress
diffus
involv
mucosa
bladder
oral
nasal
pharynx
trachea
releas
infecti
felv
secret
persist
virem
cat
dramat
contrast
tissu
distribut
felv
cat
develop
immun
regress
infect
dae
thereaft
immun
cat
develop
focma
vn
antibodi
l
dae
rojko
et
al
rice
olsen
rojko
et
al
abl
abort
viru
product
prior
widespread
marrow
epitheli
infect
recent
evid
indic
immun
cat
remain
latent
infect
felv
post
et
al
rojko
et
al
madewel
ziarrett
varmu
weiss
et
al
shown
fig
synthesi
correspond
dna
proviru
fig
l
regulatori
domain
duplic
found
end
order
r
review
varmu
weiss
et
ai
redund
term
long
termin
repeat
ltr
flank
end
entir
proviru
virusspecif
invert
repeat
base
pair
ir
redund
critic
revers
transcript
viral
rna
integr
newli
synthes
circular
felv
proviru
serv
nontranscrib
regul
express
integr
provir
dna
nucleotid
sequenc
analysi
clone
retrovir
ltr
hugh
et
ah
predict
ltr
provid
function
critic
eukaryot
gene
express
promot
initi
polyadenyl
transcript
sequenc
relat
tataa
box
probabl
determin
initi
site
transcript
question
whether
provirus
integr
random
specif
site
vivo
resolv
massinfect
popul
provir
integr
multifoc
hugh
et
al
weiss
et
recent
mullin
et
al
clone
exogen
ecotrop
felv
provirus
obtain
felvinfect
human
fibroblast
free
background
retrovirus
endogen
felin
dna
see
studi
reveal
replicationcompet
infecti
via
transfect
replicationdefect
noninfecti
felv
provirus
show
prefer
integr
site
differ
structur
proviru
integr
virusinfect
nonneoplast
ell
like
random
often
prefer
site
neoplast
cell
neel
eta
tschili
et
al
thought
either
provir
insert
caus
neoplast
event
cell
common
provlra
insert
select
expans
neoplast
clone
prefer
integr
facilit
oncogenesi
promot
insert
avian
bursal
lymphomagenesj
use
clone
probe
specif
region
ltr
exogen
felv
casey
et
al
lggl
demonstr
felvposit
lymphoma
prefer
integr
site
other
signific
leukemogen
process
comment
section
infect
cycl
cell
felv
lead
format
stabl
integr
provirus
cellular
dna
integr
provirus
liken
nasti
genet
dowri
bishop
insert
mani
site
carri
inher
potent
regulatori
element
long
termin
repeat
ltr
also
subject
host
regulatori
influenc
review
varmu
weiss
et
al
cellular
dna
domest
cat
contain
two
unrel
nucleic
acid
sequenc
homolog
two
distinct
retrovirus
repres
multipl
copi
niman
et
al
b
okab
et
al
koshi
et
al
casey
et
al
mullin
et
al
soe
et
al
eight
copi
endogen
felv
sequenc
per
haploid
genom
consist
discret
nontandemli
arrang
gene
differ
qualit
quantit
exogen
ectrop
provirus
ltr
sequenc
variabl
locat
copi
number
copi
per
cell
cat
cat
howev
sequenc
organ
differ
tissu
indic
pattern
inherit
throughout
germ
line
cell
infect
ecotrop
felv
increas
sequenc
pattern
characterist
cat
endogen
versu
exogen
sequenc
contrast
region
ltr
share
exogen
felv
serotyp
see
section
llcl
absent
endogen
felv
use
identifi
exogen
acquir
felv
sequenc
neoplast
nonneoplast
cat
cell
casey
et
al
insight
origin
organ
endogen
felv
element
provid
soe
et
al
clone
character
endogen
felv
sequenc
cat
genom
librari
construct
placent
dna
specificpathogenfre
cat
endogen
sequenc
reveal
delet
pl
env
region
render
incap
encod
infecti
viru
explain
subgenom
express
endogen
felv
placenta
noninduc
endogen
felv
cat
cell
benvenist
et
al
like
endogen
felv
origin
either
germlin
insert
complet
ecotrop
felv
subsequ
delet
insert
defect
variant
soe
et
al
felin
retrovirus
like
virus
mcallist
et
al
benvenist
et
al
unrel
felv
close
relat
baboon
endogen
retroviru
implic
natur
diseas
xenotrop
host
rang
induc
infect
felin
cell
vitro
rdllo
readili
infect
heterolog
fibroblast
isol
origin
catpassag
human
rhabdomyosarcoma
cell
et
al
although
norrnal
repress
viv
rdiil
mrna
express
placenta
age
anim
zlnd
felvposit
felvneg
tumor
nirnan
et
al
b
although
associ
specif
diseas
state
felv
b
intens
cytopath
felin
marrow
cell
vitro
onion
eta
recent
report
homolog
sequenc
share
felv
b
rnurin
retroviru
cytopath
mink
cell
mink
ceil
focusformingricfviru
rais
specul
origin
leukemogen
felv
b
elder
muilin
mcf
virus
spontan
env
gene
recombin
ecotrop
xenotrop
retrovirus
high
leukernogen
vivo
cytopathiclti
extend
host
rang
vitro
felv
b
frequent
helper
felv
implic
natur
transduct
fe
protooncogen
cat
fibroblast
result
gener
acut
transform
felin
sarcoma
virus
fesv
extrem
delay
appear
free
infecti
felv
c
plasma
may
result
rel
defect
replic
vivo
vedbrat
et
al
report
even
ceil
produc
felv
felv
felv
b
cellfre
viru
mani
partial
replic
immatur
felv
c
bud
embed
plasma
membran
suggest
partial
express
felv
c
equival
fockal
express
see
section
base
delay
appear
defect
replic
felvc
induczion
felvcdevoid
viral
stock
mani
worker
consid
felv
c
also
candid
recombin
viru
anoth
put
recombin
viru
isol
vitro
clone
felva
substrain
envelop
characterist
similar
felv
rdi
haberman
vetic
character
till
strain
pr
partli
cytopath
felin
fibroblast
vitro
induc
eoslnophil
leukemia
hypereosinophilia
vivo
lewi
et
al
enhanc
understand
relationship
env
gene
product
biolog
activ
retrovirus
kawakamitheilen
strain
felv
felvkt
mixtur
felvabc
caus
profound
erylhrosuppress
death
within
week
inocul
neonat
kitten
virtual
apathogen
weanl
adult
hoover
et
al
mackey
et
al
onion
et
al
passag
felvab
c
guinea
pig
cell
vitro
select
biolog
clone
felv
c
sarma
strain
sarma
log
felv
c
reduc
viremia
erythrojd
aplasia
vivo
suppress
erythroid
coloni
format
vitro
suggest
direct
relationship
product
felv
c
infect
anemiagenesi
onion
et
al
induct
felvrel
diseas
usual
follow
onset
marrow
origin
viremia
even
though
leukemogen
event
probabl
random
high
level
viremia
ensur
damag
viru
present
cell
appropri
histogenesi
matur
reach
critic
stage
cycl
mous
see
section
chronic
antigenemia
incit
chronic
immunostimul
uninfect
tcell
render
suscept
leukemogen
event
cat
circul
virion
protein
immunosuppress
felvpi
e
see
section
erythrosuppress
see
section
embryosuppress
hoover
et
al
progress
felv
infect
persist
polyclon
infect
follicular
lymphocyt
bone
marrow
precursor
thymocyt
associ
protract
lymphopenia
neutropenia
rojko
et
al
limit
antifelv
humor
respons
preleukemia
preced
emerg
neoplast
tcell
thymu
elsewher
rojko
et
al
hoover
et
al
princip
felvinfect
cell
lymph
node
virem
cat
nonadher
crbear
blymphocyt
rojko
et
al
diffus
larg
urn
lymphoblast
eccentr
larg
round
cleav
nuclei
promin
nucleoli
plasma
ceil
dens
function
integr
blymphocyt
replic
felv
unknown
mous
splenic
blymphocyt
concurr
infect
mulv
produc
less
antibodi
sheep
erythrocyt
uninfect
spleen
cel
probabl
due
increas
tsuppressor
activ
cerni
stiller
natur
virem
pet
cat
adequ
igm
ineffect
delay
lgg
respons
synthet
tdepend
antigen
system
thelper
defect
postul
trainin
et
al
experimentallyinduc
virem
cat
also
produc
lgm
igg
antibodi
respons
felvassoci
antigen
math
et
al
fact
may
signifi
alter
bcell
function
alter
regul
thelper
tsuppressor
accessori
cell
chang
microenviron
felvinfect
lymph
node
versu
control
lymph
node
simultan
felvassoci
peripher
blood
ymphopenia
preleukemia
rojko
et
al
redistribut
lymphoid
subpopul
also
report
preleukem
mulv
infect
gillett
fox
increas
number
crand
fc
rposit
cell
describ
preneoplast
routin
mammari
tumor
viru
infect
epstein
et
ah
probabl
mechan
import
preleukem
immunomodul
describ
section
iiici
critic
featur
distinguish
persist
product
felv
infect
persist
nonproduct
infect
viral
replic
differenti
granulocyt
macrophag
marrow
elsewher
furthermor
marrow
origin
viremia
accept
univers
harbing
fatal
felvassoci
diseas
hardi
et
al
hoover
eta
contrast
cat
regress
product
marrow
infect
develop
latent
felv
infect
see
section
hibid
refractori
myelomonocyt
seri
cell
felv
replic
correl
directli
increas
matur
even
virem
cat
experi
extens
felv
replic
myeloid
progenitor
cell
differenti
granulocyt
marrow
adher
macrophag
matur
periton
macrophag
spare
hoover
et
al
specul
deriv
uninfect
myeloid
clone
becom
refractori
abort
felv
infect
process
differenti
vivo
hoover
et
al
rojko
et
ah
relationship
macrophag
suscept
product
viral
infect
diseas
progress
also
hold
mice
infect
leukernogen
friend
mulv
complex
marcelleti
furmanski
describ
origin
mice
monkey
infect
nononcogen
virus
herp
corona
pox
flavi
virus
mogensen
daughaday
et
al
peiri
et
al
schlesing
brandriss
suscept
versu
resist
macrophag
viral
replic
central
mechan
agerel
suscept
versu
resist
viral
persist
topic
amplifi
section
felv
replic
follicular
b
lymphocyt
myelornonocyt
seri
cell
constant
featur
persist
product
felv
infect
contrast
replic
put
tcell
region
limit
recircul
lymphocyt
pool
thymi
medulla
earli
infect
rojko
et
al
disappear
replic
felv
tcell
area
preleukemia
associ
lymphopenia
rojko
et
al
cockerel
et
al
b
c
loss
circul
tsuppressor
cell
still
olsen
tcell
mitogen
function
thymicolyrnphoid
atrophi
perryman
e
al
hoover
et
al
redistribut
latent
infect
tcell
mesenter
lymph
node
rojko
et
al
preced
emerg
ol
product
infect
tlympborna
cell
subcapsular
cortic
thymu
elsewher
cockerel
et
al
rojko
et
al
neoplast
lymphocyt
trom
experimentaili
natur
infect
cat
usual
bear
tcell
marker
e
rosett
form
capac
surfac
thyrnocyt
antigen
cockerel
et
al
rare
appear
sigcbear
bcell
null
cell
rel
matur
transform
tlymphona
cell
dernonstr
lack
termin
transferas
similar
dissoci
lymphocyt
tropism
viral
replic
virusassoci
transform
observ
moloney
akr
rnurin
lymphorna
lee
lhle
isaak
cerni
implic
summar
section
vitro
agerel
suscept
see
section
kitten
versu
adult
progress
felv
infect
vivo
parallel
increment
suscept
lymphocyt
rojko
et
al
rojko
et
al
altern
differenti
suscept
freshli
isol
age
pbml
could
reflect
alter
lymphocyt
popul
present
hour
versu
hour
incub
mani
pbml
especi
unstimul
b
lymphocyt
shortliv
vitro
felin
pbml
origin
isol
viabl
hour
felin
cell
lose
fcr
within
hour
vitro
rojko
et
al
stiff
olsen
furthermor
remov
forposit
pbml
time
cultur
initi
lead
enhanc
product
infect
preincub
pbml
infect
felvr
rojko
et
al
suggest
natur
occur
fcr
cell
limit
outgrowth
felvinfect
cell
maintain
felvinfect
cell
virusnonproduct
state
similar
suppress
ebvinfect
cell
ebvnaiv
cell
fcr
known
mediat
interferon
rojko
et
al
heterogen
target
cell
suscept
infecti
felvr
investig
use
quiescent
mitogenactiv
cell
blood
spleen
lymph
node
thymu
marrow
cultur
lymphocyt
growth
factor
rojko
et
al
lymphocyt
histogenet
origin
permiss
felv
replic
activ
lymphoid
subset
differenti
mitogenesi
may
lead
enhanc
lymphocyt
surviv
vitro
gener
target
cell
dna
synthesi
favor
condit
provir
integr
replic
altern
residu
mitogen
may
inactiv
viru
mitogenactiv
lymphoblast
may
direct
antivira
activ
describ
phastimul
human
lymphoblast
expos
coxsacki
influenzavirus
lastli
activ
lymphoblast
may
suppress
outgrowth
felvinfect
cell
report
human
lymphocyt
cultur
expos
ebv
thor
eylawson
ca
felvfelin
lymphocyt
model
appear
felvinfect
shaminfect
lyrnphoblast
may
initi
spontan
exposur
mitogen
continu
growth
depend
upon
inclus
lymphocyt
condit
medium
sourc
growth
viabil
factor
rojko
et
ai
permiss
product
infect
howev
may
enhanc
felin
viral
replic
rate
ind
suggest
increas
felv
product
relat
simpli
cell
enter
mitosi
probabl
also
relat
progeni
viru
produc
per
ell
total
cell
replic
viru
murin
mammari
tumor
virusinfect
cell
trigger
messeng
rna
synthesi
associ
trigger
provir
transcript
increas
product
progeni
viru
lee
et
al
thought
complex
hormon
hostcod
receptor
interact
specif
mmtv
ltr
similarli
corticosteroid
minim
alter
replic
ecotrop
mulv
permiss
mous
cell
markedli
increas
replic
nonproduct
infect
mous
embryo
cell
dunn
et
al
either
two
hostviru
relationship
usual
ensu
cat
expos
felv
persist
viremia
culmin
felvrel
diseas
hard
et
al
hoover
et
al
rojko
et
al
selflimit
infect
product
hemolymphat
infect
transient
elicit
protect
titer
vn
focma
antibodi
cat
infect
felv
viremia
present
associ
moder
titer
focma
andor
vn
antibodi
hostviru
interact
determin
outcom
felv
infect
occur
lymphoreticular
tissu
blood
marrow
first
week
experiment
exposur
hoover
et
ah
rojko
et
al
interplay
critic
depend
upon
function
integr
tissu
agerel
irnmunocompet
cat
hoover
et
al
schaller
et
al
hoover
et
al
irojko
et
tart
et
al
describ
fulli
section
natur
oronasa
contact
felv
initi
sequenti
felv
replic
local
system
lymphoid
tissu
blood
marrow
complementassoci
nonimmun
factor
normal
cat
serum
probabl
limit
viremia
bartholomew
esser
kobilinski
et
al
known
agedepend
system
agerel
increas
immunocompet
usual
reflect
agerel
increas
macrophag
antivir
antitumor
antigen
process
function
unanu
essex
et
al
essex
et
al
grant
michalek
grant
et
al
teffector
ceil
antibodi
envelop
virion
compon
provid
protect
marrow
origin
viremia
vn
antibodi
schaller
olsen
hardi
et
al
russel
lutz
et
al
antibodi
virion
p
specul
limit
felv
replic
recent
report
propos
simultan
involv
teffector
cell
contain
felvinfect
marrow
cell
rojko
et
al
fesvtransform
autochthon
fibroblast
mccarti
grant
anemiagen
felvkt
acut
transform
fesv
sever
felv
strain
isol
natur
infect
pet
cat
although
suscept
cat
expos
felv
natur
may
vari
greatli
rate
viremia
convers
adult
urban
eat
natur
expos
felvshed
cat
multipl
cat
household
rang
factor
influenc
suscept
consid
section
vb
although
phagocyt
capac
isol
macrophag
kitten
adult
equival
mean
felv
suscept
macrophag
kitten
five
time
macrophag
adult
cat
maturationdepend
refractori
felv
replic
overcom
readili
specif
enhanc
treatment
hydrocortison
vitro
hoover
et
prednisolon
vivo
rojko
et
al
also
abrog
macrophag
poison
microcrystallin
silica
deplet
marrow
lymphoid
necrosi
induc
resorpt
carcinogen
methynitrosourea
schaller
et
al
tart
et
al
treatment
variou
dose
synthet
adren
corticosteroid
methyl
prenisolon
acet
result
augment
suscept
adult
cat
persist
felvr
persist
felvkt
viremia
cat
eventu
die
felvrel
immunosuppress
lymphoma
anemia
similar
pretreat
adult
mice
cortison
acet
enhanc
suscept
oncogenesi
moloney
murin
sarcoma
viru
schachat
et
al
distribut
felv
tissu
cat
expos
concurr
felv
prednisolon
compat
hypothesi
corticosteroid
enhanc
felv
replic
impair
felv
contain
macrophag
lymphoid
marrow
tissu
rojko
et
al
cat
treat
lower
dose
prednisolon
mgkg
hematolog
chang
specif
felvcortjcosteroid
interact
mask
overwhelm
neutrophil
leukocytosi
accompani
higher
dose
regimen
felvnaiv
felv
corticosteroid
import
regul
felv
replic
bone
marrow
myelomonocyt
precursor
also
may
infer
uniqu
capac
reactiv
latent
felv
infect
see
section
administr
silica
viru
inocul
also
markedli
enhanc
felv
suscept
adult
cat
silica
toxic
isol
macrophag
lymphocyt
vitro
silica
produc
monocytopenia
neutrophilia
delay
skin
allograft
reject
augment
focma
antibodi
respons
vivo
augment
focma
antibodi
respons
similar
seen
felvlow
dose
corticosteroid
cat
describ
probabl
reflect
intermitt
antigenemia
regressor
cat
expos
felv
fesv
b
experiment
inocul
lgg
antibodi
focma
recogn
indirect
membran
irrmunofluoresc
assay
viru
produc
felin
lymphoma
cell
first
appear
wae
persist
peak
titer
year
essex
et
al
persist
probabl
due
intermitt
stimul
foc
ia
express
latent
inf
ted
neoplast
preneoplast
cell
see
section
actual
clearanc
produc
nonproduc
neoplast
cell
probabl
mediat
cytotox
complementdepend
antibodi
cda
focma
ath
eta
grant
et
al
b
antibodi
direct
ceil
bind
rabbit
complement
appear
earli
wae
peak
earl
wae
abat
rapidli
wae
rabbit
complementfix
antibodi
caus
rapid
lysj
hour
ol
cell
correl
mifocia
antibodi
absorb
disrupt
felv
henc
like
acut
phase
cda
felv
focma
contrast
antibodi
nonvirion
determin
oj
ell
bind
cat
complement
initi
slow
ysi
hr
cell
grant
et
al
aris
later
persist
throughout
cat
lifespan
prevent
emerg
produc
nonproduc
lymphoma
cell
vivo
grant
eta
moreov
regressor
cat
serum
focia
activ
prevent
spontan
reactiv
felv
autolog
latent
infect
bone
marrow
cell
vitro
presum
unction
similarli
vivo
whether
antireactiv
activ
direct
focma
normal
marrow
leukocyt
alloantigen
intim
focma
surfac
neoplast
preneoplast
ceil
azoar
essex
grant
aichalek
dubey
et
al
lee
et
al
deserv
studi
regard
last
grant
hlichalek
examin
panel
focmacda
contain
alloantisera
panel
viru
produc
felin
lymphoma
cell
sera
identifi
singl
focma
rather
uniqu
crossreact
epitop
react
occasion
normal
splenic
lymphocyt
possibl
focma
leukocyt
alloantigen
incomplet
express
felv
c
env
gene
product
plasma
membran
discuss
section
math
qlsen
cat
die
aplast
felvrel
diseas
die
prolif
felvrel
diseas
cotter
et
al
rel
risk
lymphoma
increas
durat
viremia
obviou
cat
must
limit
marrow
origin
viremia
remain
diseas
free
protect
marrow
origin
viremia
mediat
viru
neutral
vn
antibodi
direct
subgroup
specif
envelop
schaller
olsen
hardi
et
al
hoover
et
al
de
noronha
eta
russel
lutz
et
al
bind
vn
antibodi
prevent
adsorpt
felv
cellular
felv
receptor
antibodi
biolog
activ
neutral
revers
interfer
achiev
high
titer
vivo
wae
delay
appear
like
due
dilut
serum
consumpt
felvinfect
cell
antibodi
high
vn
activ
vitro
protect
allogen
cat
passiv
transfer
either
via
colostrum
hoover
et
al
via
system
inocul
de
noronha
et
al
cotter
et
al
prevent
viremia
suscept
anim
earli
event
passiv
transfer
serum
cat
goat
hyperimmun
felv
crossreact
mulv
must
occur
within
first
dae
suscept
kitten
felv
protect
induct
marrow
origin
viremia
de
noronha
et
al
occasion
report
suggest
passiv
transfer
antibodi
lead
partial
remiss
enhanc
respons
chemotherapi
lynlphomat
cat
develop
elisa
sensit
radiolabejl
irnnunoprecipit
fluorograph
techniqu
made
possibl
observ
viremia
antibodi
coexist
lutz
et
al
math
rind
olsen
uncomnlon
cat
also
persist
lgg
focm
antibodi
titer
andor
evid
ol
antibodi
c
pi
e
cat
pattern
usuaiiy
consid
healthi
felv
carrier
probabl
maintain
antibodi
titer
year
succumb
felvrel
diseas
presenc
antibodi
excess
antigenemi
situat
may
precipit
immuneruedi
disord
includ
chronic
glomerulonephr
hypocornplementemia
kobilinski
et
al
et
al
snyder
et
al
distribut
felin
lymphocyt
marker
correl
histogenet
origin
taylor
et
aj
cockerel
et
al
b
c
rojko
et
al
rojko
et
al
ibi
rosett
assay
use
aettreat
gpe
membran
fluoresc
antifelin
thymocyt
serum
mernbran
fluoresc
antif
ine
lgg
igm
rosett
assay
use
sheep
erythrocyt
coat
antisheep
erythrocyt
rnous
complement
demonstr
cytoplasm
fluoresc
methanol
acet
acidfix
cytocentrifug
ymphocyt
prepar
use
antifelin
lgg
rosett
assay
use
sheep
erythrocyt
coat
antisheep
erythrocyt
grant
also
relev
abrog
tcell
respons
known
caus
e
discuss
section
three
piec
evid
implic
natur
killer
cell
andor
interferon
regul
felvinfect
cell
rojko
et
al
dubey
et
al
tompkin
cummin
first
demonstr
shortliv
mononuclear
cell
blood
thymu
marrow
felvnaiv
cat
limit
outgrowth
felvinfect
cell
follow
vitro
exposur
felv
see
section
similar
tsuppressor
nontsuppressor
effect
describ
ebv
known
mediat
interferon
thorleylawson
second
clinic
report
administr
interferon
anemi
virem
cat
led
partial
remiss
viremia
recoveri
anemia
tompkin
cummin
tile
third
concern
control
human
lymphoblastoid
cell
line
infect
felv
vitro
azocar
essex
dubey
et
al
lee
et
al
neoplast
tlymphoblast
suscept
product
felv
infect
nonimmunoglobulin
protein
plasma
protein
present
bovin
leukemia
viru
bolv
expos
bolvnaiv
cattl
gupta
ferrer
complement
compon
human
primat
cat
guinea
pig
lyse
retrovirus
directli
bartholomew
esser
sherwin
et
al
snyder
et
ah
schafer
schwarz
et
ah
studi
pathogenesi
regress
felv
infect
demonstr
cat
expos
contagi
felin
leukemia
viru
felv
viral
replic
contain
target
hemopoiet
tissu
elicit
humor
immun
felv
felin
oncornavirusassoci
cell
membran
antigen
focma
rojko
et
al
hypothesi
ostens
selflimit
infect
might
rather
persist
poorli
express
latent
infect
certain
hemopoiet
cell
could
account
protract
incub
period
relaps
viremia
post
et
al
persist
high
titer
antivirai
antifocma
antibodi
essex
et
al
appear
felv
antigen
serum
otherwis
nonvirem
anim
saxing
et
al
lutz
et
al
occurr
felvneg
focmaposit
leukemia
naturaiy
infect
pet
cat
hardi
eta
recent
report
detail
reactiv
latent
felv
myelomonocyt
lymphoid
cell
cat
immun
felv
tabl
post
et
al
rojko
et
al
madewel
cat
bear
felvneg
tumor
trojko
et
al
kitten
congenit
expos
felv
roiko
et
al
hoover
et
al
furthermor
suppress
reappear
felv
infect
host
immun
system
abrogog
adren
corticosteroid
rojko
et
al
therefor
latent
felv
infect
character
absenc
infecti
viru
freshli
isol
marrow
node
pbml
reactiv
vl
cultur
marrow
cell
minor
subset
nodal
lymphocyt
data
suggest
selflimit
regress
felv
infect
actual
latent
nonproduct
infect
myelomonocyt
precursor
cell
bone
marrow
spareact
cell
lymph
node
rojko
et
al
contact
exposur
studi
viru
reactiv
nonvirem
antibodyposit
cat
consid
harbor
latent
felv
madewel
found
cat
infect
soon
exposur
felv
like
develop
latent
infect
resist
contact
exposur
felv
antisoci
behavior
recov
report
differ
serum
antibodi
titer
cat
reactivat
versu
nonreactivat
infect
steroidtr
irnmun
cat
restor
antifelv
respons
lead
suppress
ol
viremia
recoveri
remain
becom
persist
virem
die
felvret
diseas
rojko
et
al
focma
titer
drop
seen
regressor
cat
seen
corticosteroidtr
progressor
probabl
indic
vivo
consumpt
suppress
adequ
humora
respons
specul
corticosteroid
induc
reactiv
shift
marrow
macrophagefelv
relationship
nonpermiss
permiss
substanti
data
provid
vitro
steroid
treatment
marrow
periton
rnacrophag
node
pbml
rojko
et
al
hydrocortison
treatment
previous
nonpermiss
periton
macrophag
reactiv
felv
marrow
macrophag
reactiv
enhanc
reactiv
oj
felv
associ
induct
cytoplasm
mean
untreat
regressor
cat
bone
rnarrow
cell
mean
cstreat
marrow
cell
conclud
steroid
amplif
viral
product
due
increas
viral
replic
fix
popul
marrow
ceil
harbor
felv
infect
matern
immun
protect
congenit
exposur
felvr
felvkt
rojko
et
al
hoover
et
al
reactivat
felv
also
found
cultur
marrow
thymu
congenit
expos
kitten
born
regressor
queen
passiv
colostr
transfer
matern
felvneutra
ize
antibodi
suckl
neonat
hoover
et
al
like
respons
mainten
neonat
infect
nonproduct
reactivat
form
rojko
et
al
reactiv
felv
marrow
tumor
cultur
g
cat
felvneg
iymphoma
interpret
evid
felv
may
factor
nonproduc
iymphomagenesi
possibl
mechan
nonproduc
lymphomagenesi
discuss
section
cotter
et
al
preleukem
leukem
cat
natur
clinic
manifest
immunomodul
includ
peripher
lymphopenia
thymicolymphoid
atrophi
circul
immun
complex
hypocomplementemia
membran
glomerulonephr
periglomerular
fibrosi
anderson
et
ah
essex
et
al
kobilinski
et
ah
jakowski
et
al
et
aj
thymicolymphoid
deplet
therefor
attribut
alter
traffic
thymocyt
precursor
marrow
thymu
alter
traffic
matur
thymocyt
splenic
nodal
paracortex
unlik
impair
cellmedi
immun
due
absenc
thymu
thymectomi
weanl
kitten
lead
alter
skin
graft
reject
lymphocyt
blastogenesi
hoover
et
aj
evid
accumul
immunoabrog
induc
felv
tcell
specif
onset
viremia
experiment
expos
cat
also
jose
capac
respond
tlymphocyt
mjtogen
concanavalin
con
phytohemagglutin
pha
antigen
keyhol
limpet
hemocyanin
kl
cockerel
et
ah
b
c
persist
infect
neutrophil
also
display
normal
chemotaxi
bacteri
kill
adduct
tcell
specif
also
support
recent
observ
natur
virem
pet
cat
make
ineffect
lgg
respons
synthet
polypeptid
multichain
ltyrosinelglutam
acid
polydlalaninepoiyllysin
denot
tgal
determin
enzymelin
immunosorb
assay
elisa
trainin
et
al
regressor
cat
math
olsen
virem
cat
howev
low
level
lgm
antibodi
reactiv
surfac
cell
aris
earli
persist
throughout
preleukemia
math
qlsen
thu
put
thelper
defect
may
assign
cat
persist
product
felv
infect
felvinduc
immunosuppress
may
provid
model
specif
impair
posit
thelper
cell
observ
follow
infect
human
cell
human
tcell
leukemia
viru
htlv
miyoshi
et
al
poiesz
et
al
popov
et
al
see
section
predispos
diseas
coomb
posit
anemia
membran
glomerulonephr
may
precipit
suppressor
cell
dysfunct
aspect
felvrel
immunosuppress
studi
evalu
suppressor
cell
function
vitro
stiff
olsen
techniqu
involv
elimin
tsuppressor
cell
shortterm
incub
hour
vitro
incub
lymphocyt
treat
mitogen
cultur
typic
lymphocyt
blastogenesi
test
normal
felin
peripher
blood
mononuclear
leukocyt
demonstr
tfold
increas
dna
synthesi
p
respons
suboptim
concentr
con
ugwel
ad
hour
rel
cell
stimul
hour
increas
dna
synthesi
cell
age
hour
vitro
interpret
mean
attenu
normal
suppress
consequ
preincub
contrast
cell
virem
cat
incub
hour
signific
increas
con
stimul
observ
stiff
qlsen
suggest
virem
cat
lack
circul
suppressor
cell
cell
function
normal
cat
normal
peripher
blood
mononuclear
leukocyt
interestingli
virem
cat
develop
depress
circul
spontan
suppressor
cell
activ
concomit
redistribut
fc
p
tcell
mesenter
lymph
node
rojko
et
al
rojko
et
al
furthermor
naturallyoccur
shortliv
cell
peripher
blood
felvnaiv
cat
known
restrict
felv
replic
condit
vitro
exposur
rojko
et
al
see
section
llialb
clearli
invers
relationship
viru
product
suppressor
cell
activ
demand
attent
b
effect
kill
felv
virion
structur
compon
immun
system
initi
evid
abrog
immun
respons
might
properti
felin
retrovirai
structur
compon
provid
schaller
et
al
addit
caus
tumor
enhanc
abrog
tumor
immun
vivo
inactiv
felv
interfer
drastic
lymphocyt
function
vivo
incub
peripher
blood
mononuclear
cell
felvnaiv
cat
serum
virem
cat
ultraviolettr
felv
vitro
caus
loss
lymphocyt
reactiv
tcell
mitogen
cockerel
et
al
math
et
al
hebebrand
et
al
allogen
leukocyt
stiff
olsen
depress
lymphocyt
membran
lectin
receptor
mobil
dunlap
et
al
lewi
olsen
hebebrand
et
al
dunlap
et
al
lewi
olsen
purifi
felv
pi
e
shown
suppress
mitogeninduc
lbt
concentr
ugwel
hebebrand
et
al
profil
similar
produc
cat
possess
progress
felvfesv
tumor
persist
virem
cat
interest
biolog
effect
felv
pi
e
lymphocyt
function
anim
host
cat
stimul
resembl
dalton
envelop
protein
murin
leukemia
viru
mulv
pl
e
ikeda
wright
felv
pi
e
possess
remark
interspeci
antigen
reactiv
distinct
interspeci
determin
felv
suggest
felv
pl
e
highli
conserv
protein
biolog
properti
restrict
homotyp
host
cat
subsequ
studi
reveal
felv
e
depress
blastogenesi
mitogen
antigen
pbml
nearli
normal
human
donor
hebebrand
et
al
felv
pio
e
also
markedli
inhibit
con
cap
human
pbml
hebebrand
et
al
dunlap
et
al
lewi
olsen
moreov
canin
bovin
equin
pbml
permiss
felv
repress
mitogeninduc
blastogenesi
studi
clearli
indic
felv
e
cross
speci
barrier
abrog
lymphocyt
prolifer
membran
receptor
mobil
recent
report
copelan
et
al
reveal
mechan
inactiv
felvand
felvderiv
plo
e
induc
repress
lymphocyt
blastogenesi
examin
factor
contribut
maxim
tcell
prolifer
reaction
con
factor
includ
product
interleukin
accessori
monocyt
secret
interleukin
tcell
growth
factor
tgcf
con
aactiv
tcell
recruit
secondari
tcell
target
respons
interleukin
tcgf
use
standard
assay
monocytedeplet
tcell
popul
requir
addit
autolog
monocyt
biolog
product
interleukin
attain
maxim
blastogenesi
preincub
monocyt
inactivatedfelv
abrog
abil
restor
blastogenesi
monocyt
deplet
pbml
diminish
secret
interleukin
respons
lipopolysaccharid
stimul
furthermor
interleukin
produc
felvtreat
monocyt
fulli
effect
initi
tritiat
thymidin
incorpor
human
cell
mous
thymocyt
lastli
addit
autolog
monocyt
felvsuppress
lymphocyt
result
partial
revers
lymphocyt
suppress
copelan
et
al
whether
protect
effect
resid
abil
monocyt
degrad
entrap
felv
pl
e
secret
factor
protect
tcell
membran
felv
e
damag
known
failur
felv
pl
e
depress
interleukin
product
accessori
function
human
monocyt
vitro
reminisc
failur
induc
dysfunct
cat
monocyt
macrophag
vitro
vivo
rojko
et
al
relev
mechan
lymphosuppress
dramat
decreas
secret
respons
tcgf
felvand
pl
e
treat
pbml
copelan
et
al
experi
monocytedeplet
tcell
incub
interleukin
con
supernat
test
tcgf
indic
prostaglandin
e
seri
effect
depressor
blastogenesi
alon
suppress
effect
depressor
conjunct
felv
pl
e
suppress
prostaglandin
howev
revers
felvinduc
cap
deficit
two
known
cyclooxygenas
inhibitor
indomethacin
nordihydroguararet
acid
ndga
revers
pl
e
suppress
con
receptor
cap
mechan
con
blastogen
respons
ndga
um
indomethacin
um
revers
suppress
ymphocyt
obtain
virem
donor
expos
felv
pl
e
vitro
lewi
et
al
inhibit
prostacyclin
synthetas
tranylcypromin
inhibitor
thromboxan
synthetas
imidazol
without
effect
studi
normal
human
donor
patient
immunosuppress
disord
cyclooxygenas
inhibitor
shown
enhanc
mitogen
respons
goodwin
webb
revers
immunosuppress
probabl
due
inhibit
pge
product
correl
posit
suppressor
cell
activ
regard
latter
lewi
et
al
accumul
cyclic
amp
reaction
con
lewi
olsen
second
phosphodiesteras
inhibitor
promot
intracellular
increment
cyclic
amp
prohibit
catabol
protect
lymphocyt
felv
suppress
enhanc
intracellular
cyclic
amp
level
lymphocyt
coexpos
felv
pl
e
con
lewi
olsen
thing
consid
highli
plausibl
origin
action
felv
pl
e
cell
membran
block
trigger
cacalmodulindepend
activ
adenyl
cyclas
altern
insert
hydrophob
bulki
pl
e
may
block
microtubul
membran
function
spaceoccupi
mechan
alon
codepress
effect
pge
felv
suppress
lectin
respons
likeji
associ
enhanc
block
membran
failur
gener
second
messeng
yclic
amp
lead
failur
transmiss
messag
prolifer
undergo
cap
respons
lectin
signal
preleukem
erythroid
aplasia
second
immunosuppress
cornmon
manifest
felv
viremia
natur
infect
cat
cotter
et
al
experimentaj
inocul
immatur
hoover
et
al
mackey
et
al
boyc
et
al
onion
et
al
testa
et
al
corticosteroidsuppress
adult
cat
anemiagen
subgroup
c
felv
felvkt
felvsarma
lead
progress
nonregen
anemia
death
week
pack
cell
volum
reflect
sever
deplet
marrow
erythroid
precursor
shift
mean
myeloid
erythrojd
e
ratio
normal
agematch
control
anem
cat
boyc
et
al
lymphopenia
sever
paracort
lymphoid
deplet
thymic
atrophi
cachexia
invari
hoover
et
al
mackey
et
al
anemia
lymphoid
deplet
may
accompani
pancytopenia
medullari
fibrosi
osteosclerosi
hemorrhag
enter
mackey
et
al
shorten
erythrocyt
lifespan
preanem
anem
cat
may
contribut
sever
anemia
hoover
eta
probabl
minor
compar
profound
select
loss
erythroid
precursor
earli
preanem
period
boyc
et
al
onion
et
al
testa
et
al
recent
colonyform
assay
fig
felin
marrow
erythroid
myelomonocyt
fibroblast
precursor
use
investig
pathogenesi
ot
preleukem
red
cell
hypoplasia
marrow
cultur
felvcinfect
cat
show
select
depress
erythropoiesi
minim
alter
granulopoiesi
boyc
et
al
onion
et
al
testa
et
al
rel
matur
erythroid
precursor
design
cfu
e
colonyform
unitserythroid
decreas
week
exposur
wae
prior
onset
anemia
boyc
et
al
dramat
rapid
fall
primit
erythroid
precursor
design
bfu
e
burstform
unitserythroid
uninfect
agematch
control
waf
wae
thereaft
testa
et
al
felvcinfect
preanem
anem
cat
myelomonocyt
precursor
cfugm
usual
unaffect
sometim
increas
transient
boyc
et
al
four
cat
also
increas
coloni
fibroblastlik
nonmacrophag
cell
attach
surfac
cultur
dish
testa
et
al
may
vitro
equival
vivo
capac
develop
rnyelofibrosi
hoover
et
al
sever
decreas
bfu
e
cfu
e
follow
viral
infect
mimic
seen
human
apjast
anemia
idiopath
origin
distinct
arrest
matur
describ
anemia
induc
friend
rauscher
murin
leukemia
virus
mulv
mous
anemia
matur
block
occur
rel
late
erythrogenesi
reflect
enhanc
cfu
e
bfu
e
number
hankin
demonstr
elegantli
anemiagen
polycythemiagen
strain
friend
viru
directli
trigger
polyclon
expans
epoposit
bfu
e
rauscher
anemia
de
et
al
erythrocyt
lifespan
reduc
drasticauy
therebi
worsen
anemia
primit
erythroid
precursor
assay
burstform
uniterythroid
bfue
bfu
e
larg
coloni
multipl
subunit
aris
day
focus
around
central
nurs
macrophag
bfu
e
probabl
requir
celltocel
contact
develop
sensit
high
level
epo
absolut
requir
bpa
produc
central
marrow
adher
macrophag
earliest
phase
bfu
e
gener
tcell
like
trigger
releas
bpa
marrow
adher
cell
colonyform
uniterythroid
cfu
e
repres
matur
commit
erythroid
precursor
cfu
e
smaller
bfue
aris
earlier
cultur
day
sensit
low
level
epo
myelomonocyt
precursor
assay
commit
stem
cell
potenti
granulocyt
monocyt
differenti
design
coloni
form
unitgranulocytemacrophag
cfugm
certain
cultur
cell
line
macrophag
urin
endotoxinactiv
serum
serv
sourc
coloni
stimul
factor
necessari
myelomonocyt
coloni
format
methyl
cellulos
mechan
underli
specif
erythroalter
subgroup
c
felv
known
man
mous
cultur
colonyform
bematopoiet
cell
identifi
stem
cell
defect
mjcroenvironrnent
disord
lymphoreticularhematopoiet
cell
interact
pathogenet
aplast
anemia
camitta
et
al
tile
sustain
myelornonocyt
precursor
activ
felvinfect
anem
preanem
cat
impli
viabl
pluripot
stem
cell
capac
myelomonocyt
differenti
argu
felvinduc
stem
cell
defect
commit
erythroid
precursor
defect
simpl
explan
might
resid
simpl
defici
erythrostimulatori
growth
factor
erythropoietin
epo
face
normal
level
coloni
stimul
factor
csf
favor
myelopoiesi
bfu
e
cfu
e
requir
epo
clonal
expans
matur
hemoglobin
bfi
e
sensit
high
level
epo
felv
induc
simpl
epo
defici
howev
improb
felv
anem
cat
marrow
refractori
exogen
epo
vitro
felv
anem
cat
elev
plasma
epo
level
vivo
hoover
et
al
plausibl
impair
felin
erythroid
ell
growth
felv
c
may
involv
viralinduc
inhibit
cell
prolifer
host
immunopatholog
reaction
felvinfect
progenitor
evid
direct
antiprolif
effect
found
bone
marrow
cell
felvnaiv
cat
expos
variou
strain
felv
vitro
assay
cfue
bfue
cffjgm
methyl
cellulos
testa
et
al
rojko
et
al
exposur
felv
c
sarma
felvab
c
kt
felvab
ohio
state
rickard
felv
felv
glasgow
rickard
felv
effect
z
reduct
cfi
e
p
fu
e
alter
cfugm
rel
shaminocul
control
minor
parallel
liquid
cultur
assay
viabil
cell
number
cellassoci
incorpor
tritiat
thymidin
show
specif
erythrodepress
independ
cytotox
effect
vitro
suppress
correl
posit
imect
input
viru
viru
replic
inocul
marrow
inactiv
felv
heat
ultraviolet
light
lead
restor
cfu
e
shaminocul
level
lmmunofluoresc
felv
cytolog
studi
indic
major
replic
viru
recov
suppress
cultur
produc
rnyelomonocyti
progenitor
cell
rojko
et
al
data
indic
anemiagen
lymphornagen
felin
retrovirus
caus
reduct
erythrogenesi
vitro
requir
infecti
viru
vitro
erythrospecifi
vivo
vitro
reminisc
friend
mulv
anemiapojyeythemia
system
infecti
viru
induc
bfu
e
enhanc
erythrogenesi
hankin
furthermor
interact
hemopoiet
cell
infecti
viru
probabl
prerequisit
anemia
induct
vivo
regard
earli
fall
bfu
e
wae
felvcexpos
preanern
cat
exactli
correl
onset
product
infect
marrow
progenitor
cell
hoover
et
al
rojko
et
al
testa
et
al
similarli
erythroid
progenitor
produc
friendmulv
complex
earli
g
hour
exposur
vivo
hankin
compel
kociba
wellman
anem
cat
cfu
e
format
decreas
absenc
autolog
serum
unaffect
presenc
normal
felvnaiv
cat
neither
inclus
pool
sera
anem
cat
addit
sera
cat
hyperimmun
felvab
c
caus
suppress
cfu
e
lastli
marrow
felvnaiv
cat
cultur
increas
amount
inactiv
felv
select
decrement
cfu
e
demonstr
inclus
purifi
virion
compon
pl
e
methyl
cellulos
cultur
system
also
lead
depress
cfu
e
kociba
wellman
question
whether
anemiagenesi
due
felv
e
replic
viru
three
deserv
studi
particular
known
specif
e
tcell
suppress
observ
bfu
e
decrement
suggest
consider
effect
felv
tcelldepend
macrophag
secret
burstpromot
activ
kociba
wellman
studi
particular
known
specif
pl
e
tcell
suppress
observ
bfu
e
decrement
suggest
consider
effect
felv
tcelldepend
macrophag
secret
burstpromot
activ
kociba
wellman
mani
oncogen
retrovirus
includ
felin
avian
murin
bovin
gibbon
ape
human
tcell
leukemia
virus
murin
mammari
tumor
viru
induc
neoplasm
long
latent
period
month
year
review
gilden
rabin
weiss
except
human
tcell
leukemia
viru
htlv
virus
immort
cell
vitro
yamamoto
et
al
appear
contain
viral
transform
gene
gilden
irabin
often
persist
intact
proviru
requir
induct
mainten
transform
state
fulli
onethird
felin
lymphoma
neg
felv
antigen
neg
sensit
indic
felv
provirus
koshi
et
al
casey
et
al
current
favor
mode
oncogenesi
long
latenc
leukemia
virus
includ
activ
conc
sequenc
directli
promot
insert
hayward
et
al
activ
transform
gene
cooper
indirectli
insert
mutagenesi
regulatori
cellular
sequenc
indirect
viral
effect
viru
viral
receptor
trigger
seri
blastogen
respons
mediat
interleukin
hormon
viru
final
carcinogen
mcgrath
et
al
ihl
gener
highli
transform
recombin
virus
extend
host
rang
elder
et
al
leukemia
acceler
virus
nowinski
et
al
propos
mechan
oper
felin
leukemogenesi
must
account
certain
observ
first
neg
correl
lymphoid
target
product
infect
target
transform
cockerel
et
al
b
rojko
et
al
face
posit
correl
felv
viremia
likelihood
neoplasia
see
section
second
similar
potenti
cytopath
felv
b
cytopath
murin
recombin
virus
high
leukemogen
elder
mujlin
third
role
immunoselect
versu
immunosuppress
emerg
expans
leukem
clone
penultim
present
ident
focma
relationship
viru
produc
nonproduc
neoplasia
last
controversi
etiolog
nonproduc
lymphoma
leukemia
studi
pathogenesi
virem
felv
infect
establish
bbut
tcell
replic
felv
constant
featur
preleukemia
felv
ultim
transform
tceil
marrow
blood
origin
migrat
thymu
cockerel
et
aj
b
rojko
et
al
similar
dissoci
viru
replic
transform
occur
moloney
lee
ihj
isaak
cerni
akr
murin
leukemia
lee
lhle
eider
et
al
lee
lhle
leukemiaacceler
virus
nowinski
et
al
passiv
antibodi
protect
mice
tcell
neoplasm
administ
earli
preleukemia
potent
oncogen
recombin
ecotrop
akv
produc
nonthyrnocyt
xenotrop
viru
produc
thymocyt
cell
capabl
gener
recombin
identifi
critic
role
thymic
nurs
cell
jeukemogenesi
vivo
suggest
consider
haa
recombin
event
usual
specif
env
region
progeni
recombin
homolog
xenotrop
ecotrop
env
gene
product
known
see
section
iici
determin
host
rang
biolog
properti
target
vn
antibodi
host
rang
extend
includ
xenotrop
ecotrop
ceil
call
amphotrop
newli
evok
cytopath
mink
cell
lieu
transform
gene
capac
led
design
mink
cell
focusform
mcf
viru
mani
parallel
drawn
felv
leukemogenesi
passiv
antibodi
felv
protect
administ
within
first
dae
de
noronha
et
al
subgroup
felv
long
latenc
leukemia
virus
highli
restrict
host
rang
felv
replic
effici
cat
cell
strain
replic
ineffici
human
canin
cell
sarma
log
elder
et
al
regard
perhap
use
note
origin
felv
isol
felvrickard
weakli
leukemogen
ohio
state
strain
felvr
contain
felva
felv
b
highli
leukemogen
hoover
et
al
glasgow
strain
felvr
contain
felv
mimic
parent
felvr
weak
pathogen
moreov
felv
b
highli
cytosuppress
normal
felin
marrow
lymphoid
cell
vitro
onion
et
al
see
section
iici
whether
cytodepress
properti
due
virion
pl
e
effect
due
superinfect
unintegrat
henc
toxic
provirus
similar
describ
cytopath
avian
leukemia
virus
ler
et
al
known
data
propos
felv
b
mcflike
leukemia
acceler
viru
reinforc
recent
molecular
evid
nucleotid
sequenc
envv
gene
felv
b
reveal
uniqu
sequenc
homolog
murin
mcf
viru
elder
mullin
although
absolut
prerequisit
lymphomagenesi
viremia
increas
probabl
decreas
latent
period
transtorm
event
leukemogen
event
usual
consid
random
howev
high
replic
viru
burden
increas
probabl
new
provir
integr
sensit
site
sensit
cell
avian
bursal
lymphoma
sequenc
upstream
cellular
homologu
avian
myelocytomatosi
viru
protooncogen
design
cmyc
integr
provir
ltr
suffici
initi
express
cmyc
rna
induc
transform
phenotyp
viru
produc
viru
nonproduc
cell
lymphoma
express
cellular
transform
gene
unrel
viral
transform
gene
recogn
dna
transfect
indic
fibroblast
evok
transform
cooper
gene
may
encod
transform
protein
relat
transferrin
famili
induct
bursal
lymphoma
probabl
via
downstream
promot
via
insert
mutagenesi
regulatori
sequenc
normal
function
ensur
repress
present
evid
downstream
promot
insert
mutagenesi
felv
lymphomagenesi
compel
replicationcompet
provirus
felvposit
lymphoma
caus
viral
replic
transform
nih
felin
fibroblast
replicationdefect
provirus
felvposit
tumor
dna
felvneg
tumor
caus
neither
product
infect
transform
transfect
assay
casey
et
al
rosenberg
et
al
critic
specif
immunostimul
uninfect
tcell
moloney
mulv
leukemogenesi
akr
balbc
mice
ihl
target
howev
improb
tcell
subset
restrict
equal
pi
e
rojko
et
al
select
depress
antivir
teffector
thelper
cell
trainin
et
al
could
allow
emerg
neoplast
subset
whose
prolifer
uncheck
pi
e
furthermor
specif
failur
iggfocma
humor
immunosurveil
see
section
iiib
would
jow
surviv
emerg
neoplast
cell
induct
protect
felv
infect
neoplast
felv
proviru
could
protect
cell
frorn
nk
lysi
dubey
et
al
gener
consensu
felin
hemolymphoreticular
rnesenchym
neoplasm
distinguish
felin
oncornavirsassoci
cell
membran
antigen
focma
focmal
express
felvabcproduc
felin
lyrnphoma
line
defin
imi
use
virem
immun
cat
serum
princip
target
imrnunosurveil
see
section
iilb
controversi
regard
identif
nonvirion
versu
virion
encod
protein
tumorspecificantigen
rampant
see
focma
gener
concomit
morpholog
transform
cell
common
strain
fesv
snydertheilen
stsnyder
theilen
lzag
sequenc
transcript
gagf
sequenc
integr
fesv
proviru
integr
depend
upon
felv
b
help
yield
polycistron
mrna
translat
precursor
protein
ps
fe
protein
kinas
activ
specif
tyrosin
residu
barbacid
et
al
franchini
et
al
ggl
hamp
et
al
verones
et
al
phosphoryl
protein
tyrosin
uniqu
retrovir
transform
gene
product
prototyp
pojyprotein
src
translat
product
vsrc
csrc
avian
rou
sarcoma
viru
collett
erikson
current
thought
transform
due
phosphoryl
tyrosin
residu
protein
respons
membranemedi
regul
cell
shape
adhes
motil
prolifer
particular
src
phosphoryl
vimentin
protein
attach
actin
inner
face
plasma
membran
preserv
normal
cytoskeleton
src
bind
phosphoryl
cellular
receptor
epiderm
growth
factor
suggest
src
may
disturb
regul
cell
prolifer
conclus
focma
although
heterogen
probabl
transform
protein
felin
sarcoma
viru
encod
transduc
cellular
gene
helper
felv
sequenc
earli
observ
focma
focmal
antigen
crossreact
led
hypothesi
felv
induc
conc
sequenc
transform
cell
focmal
thu
induc
tumorspecif
antigen
essex
eta
b
hardi
et
al
hardi
et
al
strengthen
appar
dissoci
express
focmal
felv
structur
protein
focma
present
nontransform
felvinfect
fibroblast
lymphocyt
sliski
eta
fleissner
snyder
felv
protein
absorb
focma
activ
natur
occur
virem
cat
sera
essex
et
al
b
stephenson
eta
vn
antifocma
imi
cda
activ
cat
sera
correl
essex
et
al
b
focma
express
surfac
nonproduc
felin
lymphoma
cell
furthermor
dalton
protein
immunoprecipit
felvneg
lymphoma
cell
shown
tryptic
peptid
map
analog
dalton
protein
felvposit
iymphoma
origin
fleissner
snyder
recent
observ
cast
doubt
relationship
focmal
focma
consid
focmal
express
correl
express
felv
c
epitop
transform
phenotyp
first
observ
fesvencod
polyprotein
nonproduc
mink
cell
immunoprecipit
focma
antibodyposit
sera
either
regressor
natur
virem
cat
barbacid
et
al
also
neither
sera
refer
monospecif
antisera
vfe
gene
product
immunoprecipit
protein
cell
protein
kinas
activ
virem
cat
sera
im
focmal
activ
usual
neg
focma
imi
assay
vedbrat
et
al
second
focmal
express
strong
felvkt
felvabc
infect
felin
embryo
fibroblast
human
lymphocyt
essex
et
al
impress
evid
found
recent
report
vedbrat
et
al
focma
antibodyposit
sera
natur
virem
cat
react
felv
c
epitop
express
bud
viru
cell
surfac
felin
lymphoma
felvcinfect
fibroblast
ident
epitop
felv
come
extens
analysi
use
monoclon
antibodi
focmal
felv
c
identif
focmal
translat
product
felv
c
env
sequenc
pose
appar
dilemma
lymphomainduc
felv
usual
subgroup
ab
c
prototyp
lymphomagen
felvr
produc
felin
lymphoma
ceil
line
felv
fibroblast
infect
viru
express
focmal
felv
c
antigen
howev
parent
cell
express
felv
c
virion
incomplet
bud
plasma
membran
vedbrat
et
al
felv
c
absorb
activ
monoclon
antibodi
focmal
felv
c
monoclonai
distinguish
three
antigen
determin
felv
c
molecul
monoclon
recogn
antigen
express
bud
viru
cell
membran
mask
alter
matur
virion
cross
reactiv
cat
antisera
focma
monoclon
discrimin
epitop
restrict
infecti
felv
c
virion
monoclon
identifi
epitop
common
infecti
noninfecti
felv
c
particl
even
focmal
virallyencod
cellderiv
antigen
even
express
felvcinfect
fibroblast
vitro
still
antigen
evok
protect
immun
progress
felvinduc
tumor
vivo
grant
michalek
argu
focmal
singl
epitop
complementdepend
cytotox
antibodi
focma
present
sera
natur
infect
pet
cat
specifi
uniqu
crossreact
antigen
individu
tumor
extrem
interest
see
epitop
identifi
monoclon
felv
c
vitro
con
epitop
identifi
vivo
natur
infect
cat
observ
noninfecti
felv
c
particl
shed
cell
absorb
focmal
activ
natur
infect
pet
cat
sera
make
import
consid
solubl
focmal
known
secret
spent
cell
vitro
hede
et
al
virem
nonvirem
cat
lutz
et
al
saxing
et
al
vivo
also
ident
noninfecti
felv
c
particularli
relev
solubl
focma
serv
primari
immunogen
highli
protect
felv
vaccin
schedul
commerci
releas
near
futur
hede
et
ah
express
felv
c
env
gene
infect
fibroblast
vitro
necessarili
relev
express
focmal
hemolyrnphoreticular
cell
vivo
fibroblast
commonli
infect
cat
rojko
et
ah
sinc
cat
expos
felv
vivo
usual
develop
antibodi
focmal
focmal
must
express
nonvirem
virem
cat
vivo
rice
olsen
sever
line
evid
suggest
felv
leukemogenesi
restrict
cat
product
felv
infect
virusneg
lymphoma
account
felin
lsa
occur
protract
latenc
period
older
cat
hardi
et
al
cat
virusneg
focmaposit
lymphoma
origin
felvinfect
household
virusneg
lymphoma
describ
felvexpos
kitten
render
regressor
passiv
immunotherapi
de
noronha
et
al
complementdepend
focma
antibodi
protect
nonproduc
leukemia
grant
et
al
b
virusneg
leukem
cat
circul
immun
complex
contain
viral
revers
transcriptas
day
et
al
et
al
snyder
et
al
moreov
sixti
percent
nonvirem
cat
lymphoma
low
level
serum
saxing
et
al
nonvirem
preleukem
cat
intermitt
marrow
focmal
express
long
regress
acut
infect
lastli
strong
evid
implic
felv
genesi
nonproduc
lymphoma
provid
demonstr
cat
virusneg
lymphoma
leukemia
latent
reactivat
bone
marrow
infect
felv
rojko
et
al
argument
felv
involv
nonproduc
lymphomagenesi
also
weighti
nonproduc
np
lymphoma
heterogen
morpholog
tissu
distribut
epidemiolog
virolog
np
tumor
usual
multicentr
alimentari
leukem
thymic
origin
hardi
et
al
rel
high
proport
bear
slg
null
cell
marker
also
includ
myelomonocyt
leukernia
madewel
erythem
myelosi
larg
granular
lymphocyt
leukemia
eosinophil
leukemia
system
mastocytosi
cutan
mycosi
fungioid
rojko
et
al
nonproduc
lymphoma
leukemia
need
origin
cat
felvendem
multipl
cat
household
often
occur
randomli
furthermor
felvneg
tumor
often
carri
retrovir
inform
particularli
foami
felin
syncyti
endogen
felv
provirus
casey
et
al
specif
evid
contrari
involv
felv
nonproduc
lymphoma
includ
absenc
cytoplasm
surfac
replic
felv
tumor
nontumor
cell
hardi
et
al
koshi
et
al
saxing
et
al
casey
et
al
rojko
et
al
madewel
vedbrat
et
al
four
nonproduc
lymphoma
neg
surfac
focmal
felv
c
epitop
identifi
monoclon
antibodi
vedbrat
et
al
furthermor
nonproduc
lymphoma
reactivat
marrow
origin
felv
madewel
rojko
et
al
studi
employ
dna
clone
probe
hybrid
np
tumor
cell
neg
complementari
dna
felv
rna
koshi
et
al
absolut
devoid
exogen
felvspecif
u
ltr
sequenc
casey
et
al
absenc
exogen
u
sequenc
mean
np
cell
never
integr
felv
provirus
therefor
never
experienc
horizont
transmit
infect
furthermor
reactiv
felv
np
marrow
necessit
role
felv
np
lymphomagenesi
may
presenc
overwhelm
tumor
burden
lead
stressinduc
corticosteroidtrigg
rojko
et
al
marrow
felv
recrudesc
assumpt
felv
associ
etiolog
np
lymphoma
correct
lack
exogen
u
sequenc
tumor
cell
would
suggest
intact
felv
proviru
requir
initi
transform
similar
hit
run
mechan
describ
vitro
transform
ell
rou
sarcoma
viru
herp
simplex
viru
progress
loss
viru
genom
accompani
transform
review
gilden
rabin
support
premis
come
analysi
u
ltr
sequenc
tumor
ceil
cat
felvposit
yrnphoma
casey
et
al
exogen
acquir
provirus
tumor
may
demonstr
simpl
u
hybrid
pattern
discret
number
singlecopi
provirushost
junction
fragment
n
tumor
acquisit
proviru
may
respons
tumor
initi
altern
cell
pattern
may
select
clonal
expans
felvposit
tumor
provir
integr
independ
transform
event
great
divers
provir
sequenc
interpret
mean
transform
uninfect
cell
preced
superinfect
exogen
felv
casey
eta
socioepidemiolog
factor
influenc
felvcat
relationship
subject
thorough
discuss
elsewher
benvenist
et
al
show
virus
diverg
million
year
ago
time
ancestr
cat
confin
arid
reach
northern
africa
rattocat
transmiss
transfect
retrovir
inform
thought
consequ
preytopred
relationship
whether
cat
bit
rat
rat
bit
cat
lost
histori
prevail
climat
arid
natur
felin
independ
probabl
restrict
horizont
transmiss
mani
year
infertil
virem
queen
cotter
et
al
hoover
et
al
ensur
low
preval
congenit
transmiss
day
antisoci
feral
cat
protect
exposur
readili
inactiv
viru
franci
et
al
incid
exposur
freerang
minim
domest
cat
india
felv
extrem
low
domest
particular
congreg
cat
multipl
cat
household
mch
favor
cattocat
transmiss
felv
perman
resid
mch
lieu
felv
test
remov
program
felin
behavior
instinct
lick
groom
etc
commun
water
dish
litter
pan
found
mch
provid
protect
moistur
felv
allow
effici
horizont
transmiss
social
cat
exposur
cat
abl
resist
progress
felv
replic
initi
local
system
lymphoreticular
contain
see
section
iilgll
immun
cat
retain
latent
felv
provirus
marrow
lymphoid
ell
eventu
consequ
increas
felv
preval
mch
emerg
felv
viremia
felvrel
diseas
emerg
may
precipit
overcrowd
stress
intercurr
infect
also
concentr
mch
environ
surpris
therefor
first
recognit
viral
etiolog
felin
lymphoma
subsequ
isol
cellfre
transmiss
viral
agent
catteri
glasgow
high
frequenc
alimentari
thymic
lymphoma
diseas
natur
occur
experiment
stimul
mch
provid
evid
horizont
transmiss
felv
mch
influenc
viremia
immun
produc
nonproduc
felvrel
diseas
document
extens
reader
refer
elsewher
detail
much
made
predisposit
felv
virem
cat
develop
intercurr
viral
bacteri
parasit
infect
cotter
et
al
role
felv
pl
e
mediat
immunosuppress
thymicolymphoid
deplet
overst
see
section
iiicl
factor
demand
consider
mch
often
hotb
felin
pathogen
activ
cat
attend
show
permit
roam
return
introduc
new
pathogen
assimil
readili
rel
vulner
popul
household
contain
kitten
incomplet
immunocompet
pathogen
may
becom
fulmin
particular
viru
often
found
mch
special
tropism
lymphoreticular
tissu
kelv
virem
cat
felin
infecti
periton
coronaviru
fipv
cotter
et
al
horzineck
osterhau
report
cat
fatal
fipv
infect
concurr
virem
felv
salient
clinicopatholog
featur
progress
fipv
infect
includ
hypergammaglobulinemia
immun
complex
antigen
igc
deposit
renal
glomeruli
vessel
elsewher
indic
excess
immunostimul
henc
ineffect
regulatori
cell
activ
whether
specif
tsuppressor
defect
induc
felv
allow
progress
immunemedi
fipv
diseas
known
altern
explan
frequent
associ
two
diseas
fipvinduc
polyclon
activ
fekvrepl
lymphoid
subset
might
iacilit
vivo
reactiv
felv
latent
inlect
cat
anoth
viru
possibl
relev
felin
panleukopenia
viru
although
excel
attenu
viral
vaccin
current
market
ramif
routin
vaccin
virem
latent
infect
cat
studi
regard
latter
associ
recurr
canin
distemp
viru
infect
exposur
canin
parvovirus
discount
krakowka
et
al
like
canin
parvoviru
felin
panleukopenia
viru
pronounc
tropism
lymphohernatopoiet
tissu
carlson
et
al
may
initi
transient
protract
lymphornyeloid
dysfunct
major
import
felvcat
model
tool
specifi
natur
occur
experiment
demonstr
pathogenet
factor
independ
regul
viru
replic
virusassoci
cytosuppress
cytoprolif
diseas
infect
felv
highli
reproduc
prospect
studi
conduct
anim
expect
undergo
acut
persist
product
latent
infect
prescrib
period
time
interdepend
immun
respons
subsequ
develop
cancer
accept
gener
whether
irnmunosuppress
preced
neoplasia
whether
neoplasia
caus
immunosuppress
remain
controversi
littl
doubt
howev
emerg
clonal
expans
neoplast
ell
vivo
must
accompani
escap
normal
surveil
sever
anim
model
retrovirus
identifi
caus
lymphohematopoiet
neoplasia
virus
associ
dramat
loss
immunocompet
shortli
infect
see
section
iiici
felin
system
particular
interest
immunosuppress
initi
viru
infect
preced
detect
neoplast
transform
month
perryman
et
al
hoover
et
al
cockerel
et
al
b
c
fact
frequent
caus
death
natur
felv
virern
cat
felvassoci
bacteri
viral
infect
cotter
et
al
essex
et
al
profound
depress
ceilmedi
immun
facilit
establish
progress
otherwis
innocu
opportunist
perryman
et
al
hoover
eta
cockerel
et
al
b
c
depress
appar
specif
tcell
particularli
thelper
trainin
et
al
tsuppressor
stiff
olsen
cell
failur
thelper
cell
probabl
lead
ineffect
humor
surveil
focmabear
preneoplast
neoplast
cell
immunomodul
favor
high
level
viremia
ensur
uninfect
tcell
expos
virion
envelop
compon
pio
e
immunosuppress
virion
compon
alter
product
recept
tcell
growth
regulatori
factor
copelan
eta
capac
hydrophob
surfac
protein
probabl
insert
plasma
membran
tcell
alter
intracellular
messag
influenc
cyclic
nucleotid
prostaglandin
system
lewi
et
al
addit
use
anim
model
gener
lymphosuppress
found
cancer
intens
studi
mechan
immunosuppresson
virem
cat
provid
inform
relev
immunosuppress
accompani
human
retrovira
infect
human
htlvendem
area
high
incid
pneumonia
filariasi
htlvtransform
cell
thelper
phenotyp
htlv
probabl
infect
thelper
tsuppressor
cell
miyoshi
et
al
poiesz
et
al
popov
et
al
importantli
observ
recent
htlv
may
provok
assist
specif
thelper
loss
defin
acquir
irnmunodefici
syndrom
aid
predispos
death
via
kaposi
sarcoma
pneumocysti
pneumonia
opportunist
pathogen
review
franci
et
al
etiolog
pathogenesi
human
aplast
anemia
remain
obscur
diseas
character
select
loss
erythroid
progenitor
without
matur
arrest
vivo
sever
decreas
bfii
e
cffu
e
assay
vitro
consid
contributori
pathogenesi
stem
cell
defect
disord
microenviron
abnorm
lymphoreticularhematopoiet
cell
interact
camitta
et
al
ent
report
ol
human
parvoviruslik
viru
profound
erythrosuppress
effect
vivo
vitro
add
virus
list
potenti
pathogenet
factor
mortim
et
al
ritic
cell
appear
primit
erythroid
progenitor
bfue
depend
high
level
erythropoiet
epo
burstpromot
activ
bpa
prolifer
clonal
expans
hemoglobin
bpa
thought
produc
marrow
accessori
rnacrophag
tcell
depend
process
lymphoma
leukemia
l
esearch
long
recogn
etiolog
relationship
oncogen
retrovirus
develop
leukemia
lymphoma
sarcoma
nonhuman
speci
review
see
rabin
weiss
et
al
two
cogent
implic
retrovirus
tile
induct
human
leukemia
provid
recent
cellular
gene
analog
retrovir
onc
gene
present
frequent
transcrib
human
tumor
cell
induc
fibroblast
transform
demonstr
transfect
assay
cooper
may
activ
transloc
subsequ
ebvinduc
lymphoprolifer
vivo
klein
lymphoblast
htlv
mark
tropism
thelper
tsuppressor
lymphocyt
identifi
monoclon
antisera
miyoshi
et
al
poiesz
et
al
popov
et
al
gotoh
et
al
exposur
freshli
isol
htlvnaiv
human
cord
blood
lymphocyt
cellfre
htlv
initi
persist
nonproduct
htlv
infect
growth
rel
shaminfect
control
rojko
et
al
vital
use
felin
model
document
humor
cellular
surveil
product
latent
infect
cell
vivo
particular
factor
influenc
oncogen
viru
latenc
mandat
descript
light
recent
observ
peopl
immun
prospect
human
oncogen
htlv
remain
latent
infect
htlv
gotoh
et
al
data
gener
felvfelin
lymphoma
model
may
generaliz
human
infect
latentreactivat
virus
associ
develop
cancer
